Jumalon, Virginia V.

HRN: 26-20-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/13/2024
11/20/2024
IV
2.25grams
Q8H
Infected Mandibular Mass
Waiting Final Action 
11/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/13/2024
11/20/2024
IV
300mg
Q6H
Infected Mandibular Mass
Waiting Final Action 
11/14/2024
CEFUROXIME 750MG (VIAL)
11/14/2024
11/21/2024
IV
750
Q8
Uti, Mandibular Mass With Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: